During the past decade, East Coast Institute for Research, LLC conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Coast Institute for Research, LLC" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Bayer" with 2 trials sponsored, "Angel Medical Systems" with 1 trials sponsored, "East Coast Institute for Research" with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Coast Institute for Research, LLC" #1 collaborator was "Dallas Diabetes Research Center" with 1 trials as a collaborator, "Insulet Corporation" with 1 trials as a collaborator, "Janssen Biotech, Inc." with 1 trials as a collaborator, "Symbios Clinical" with 1 trials as a collaborator and "Valeritas, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "East Coast Institute for Research, LLC" are "Type 2 Diabetes" (3 trials), "Type 2 Diabetes Mellitus" (3 trials), "Diabetes" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Myocardial Infarction (AMI)" (1 trials). Many other conditions were trialed in "East Coast Institute for Research, LLC" in a lesser frequency.

Most popular intervention types in "East Coast Institute for Research, LLC" are "Drug" (10 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Insulin Degludec" (2 trials), "Insulin Efsitora Alfa" (2 trials), "Tirzepatide" (2 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "East Coast Institute for Research, LLC" are 12 trials for "All" genders.

Currently, there are NaN active trials in "East Coast Institute for Research, LLC". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in East Coast Institute for Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in East Coast Institute for Research, LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".